📰 Daniel Hoft News
Daniel Hoft News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Daniel Hoft. Real-time updates on events, politics, business and more.
January 5, 2024
Saint Louis University Medical CenterNews, press releases, and expert sources for journalists in science, medicine & business
September 3, 2022
Saint Louis University researchers are currently working on a new COVID-19 vaccine trial. Researchers are almost done with the first of three phases.
June 5, 2022
A roundup of some of the most popular but completely untrue stories and visuals of the week. None of these are legit, even though they were shared widely on social media. The Associated Press checked them out. Here are the facts:
June 4, 2022
CLAIM: A new study from researchers at the National Institutes of Health and Moderna shows COVID-19 mRNA vaccines “hurt long-term immunity to Covid after infection.”
June 3, 2022
A roundup of some of the most popular but completely untrue stories and visuals of the...
March 3, 2022
Poolbeg Pharma makes excellent progress post IPO and momentum building
November 25, 2021
Poolbeg Pharma US infectious diseases expert, Professor Daniel Hoft, joins Scientific Advisory Board
November 25, 2021
A selection of the stories appearing in the Proactive website today
June 10, 2021
Dr. Daniel Hoft is the director of the Saint Louis University Center for Vaccine Development.
March 9, 2021
Instead of a 'one bug, one drug' approach, could a single vaccine work against all coronaviruses?